key: cord-0965606-8jyeqpze
authors: Dayanand, Divya; Irudhayanathan, Indhuja; Kundu, Debasree; Manesh, Abi; Abraham, Vinod; Abhilash, Kundavaram PP; Chacko, Binila; Moorthy, Mahesh; Samuel, Prasanna; Peerawaranun, Pimnara; Mukaka, Mavuto; Joseph, Jayaraj; Sivaprakasam, Mohanasankar; Varghese, George M
title: Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention
date: 2021-12-28
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.12.356
sha: 64f33f40ebd6baff2cc615d54635a9be4fad188e
doc_id: 965606
cord_uid: 8jyeqpze

Objectives To inform public health policy decisions through assessment of IgG antibody seroprevalence in the population and the risk factors for SARS-CoV-2 infection. Methods We estimated the seroprevalence of IgG antibodies among different subpopulations at the end of the first and second waves of the pandemic. We also assessed various risk factors associated with the seropositivity including socio demography, IgG antibodies against endemic human coronavirus and vaccination status. Results Of the 2433 consented participants, the overall estimated seroprevalence at the end of first and second waves were 28.5% (95% CI:22.3%-33.7%) and 71.5% (95% CI:62.8%-80.5%), respectively. The accrual of IgG positivity was heterogeneous, with highest seroprevalence among the urban slum population(75.1%). Vaccine uptake was varied among the subpopulations, with low rates (<10%) among the rural and urban slums. The majority of seropositive individuals (75%) were asymptomatic. Residence in urban slums (OR 2.02; 95% CI:1.57-2.6; p<0.001), middle socioeconomic status (OR 1.77; 95% CI:1.17-2.67; p=0.007), presence of diabetes (OR 1.721; 95% CI:1.148-2.581; p=0.009), and hypertension (OR 1.75; 95% CI:1.16-2.64; p=0.008) were associated with seropositivity on multivariable analyses. Conclusion Although considerable population immunity has been reached with more than two-thirds seropositivity, improved vaccination strategies among unreached subpopulations and high-risk individuals are suggested for better preparedness in future.

The coronavirus disease pandemic has caused an unprecedented public health challenge in India with over 32 million confirmed cases and over 400 thousand deaths as of the end of August 2021(JHU CSSE 2021) .India had a universal, strict lockdown which started in March 2020 as the pandemic started, and lasted for several months.This provided a window of opportunity to prepare the healthcare system and helped in flattening the epidemic curve and reducing mortality.Afterthe first wave, by the end of January 2021, a low case fatality rate (CFR) of 1.4%was reported with154,428deaths among the 10.76 million cases (Purkayastha et al.,2021) . However, the second wave which was largely caused by the delta variant caught the nation uninformed with its rapidity and magnitude.A much greater number of cases were reported during the second wave when compared with the first; andIndia's most recent serosurvey which is yet to be published shows that two-thirds of the Indian population carries antibodies against COVID-19 either because of prior exposure to the virus or a vaccine (Anand et al.,2021) .

A serosurvey from 70 districts across India conducted between December 2020 and January 2021 reported a population-weighted seroprevalence of 24.1% (Murhekar et al.,2021) . However, a cross-sectional study conducted among people living in urban slums during a close timeperiod reported a much higher seroprevalence of 57.9%(George et al., 2021) . The extent of the spread of infection into the general population is underestimated, as themajority of the infections are pre-symptomatic or asymptomatic(Wuet al.,2020). Indeed, there is heterogeneity in the transmission dynamics and a resultant seroprevalence among the population. A vast majority(90-99%) of transmission in the community is reported to be asymptomatic(George et al., 2021 , Kshatriet al.,2021 .Such asymptomatic cases complicate and prevent reliable estimation of transmission and tracking strategies for containing the spread of infection.Nevertheless, asymptomatic infections contribute substantially to community transmissionand population immunity (Oran et al., 2020) .Based on the seroprevalence and proportion of asymptomatic transmission in the community, the estimated infection fatality rate (IFR) in Indiais reported to be 0.04% which is lower when compared to the reported IFR of 0.31% from high-income countries like the USA during the same period (Laxminarayan et al., 2021 , Pei et al.,2020 .This could be due to due to a much younger median age of the population.Whether factors such as pre-existing seasonal coronavirus antibodies offer any partial cross-protection leading to milder or asymptomatic disease is unclear (Anderson et al.,2021 , Song et al.,2021 .As the number of cases has come down significantly and subsequent return to near normalcy is seen in most states, studying the current seroprevalence and vaccination rates in the community could inform future response and prevention strategies. This cross-sectional studyassesses the seroprevalence of IgG antibodies to SARS-CoV-2 infection in Vellore district of Tamil Nadu and compares the same among participants across four different subpopulations:urban slum, urban affluent,rural areas, and healthcare workers (HCW). We investigated the IgG seropositivity at two time periods, at the end of wave 1(January 2021) and wave 2(July 2021) in the four subgroups. We also evaluated various risk factors associated with SARS CoV-2 infection:IgG antibodies against two other endemic strains (NL63 and OC43) of human coronaviruses (HCoV)to evaluate possible cross-protection to the SARS-CoV-2 and vaccination status at the end of wave 2.The seropositivity rates at the end of wave 1 and wave 2 combined with the vaccination status at the end of wave 2 in the four subgroups will provide valuable insights on the proportion of populationimmunity developed against SARS-CoV-2 infection. Based on this information subgroups that warrant attention can be targeted for futureprevention strategies.

This cross-sectional serosurvey was performed among the permanent residents of Vellore district, Tamil Nadu in South India at two time periods: January 2021, at the end of wave 1 and July 2021, at the end of wave 2 ( Figure 1 ). Vellore district with six taluks (Vellore, Katpadi, Gudiyattam, Anaicut, Pernambet, and KV Kuppam) had 57% of the population living in rural areas and 43% in urban areas according to the 2011 census. Villages in each of the taluks were randomly selected for the survey. Additionally, two different subpopulations in theurban area of Vellore, namely urban slums and urban affluent areas, were also surveyed separately. The survey team randomly chose willing participants of all age groups from each sampling area. A minimum ofthirty individuals were enrolled from each random location and a total of 250 individuals were enrolled from each subpopulation. Healthcare workers who were willing to take part in the study were recruited from among doctors, nurses, paramedical staff, and support staff ofChristian Medical College (CMC), Vellore.

Individuals who agreed to participate answeredan interviewer-based semi-structured questionnaireafter providing a written informed consent or assent as applicable. The questionnaire comprised of questions related to socio-demographic variables including age, gender, socioeconomic status, comorbidities, respiratory symptoms or fever inthe 6 months prior to enrolment in the study, hospitalisation for COVID-19 since March 2020, and mask usage in the workplace and public places. Vaccination statusby the second wave was also included in the questionnaire at the end of wave 2. After administration of the questionnaire, a 5 ml blood samplewas drawn from the participants and transportedin a sample carrier box with gel packs to the laboratory where they were centrifuged.Plasmasamples were collected and stored at -70 °C untilIgGELISAtesting wasdone. SARS-CoV-2 serological testing was done using SCoV-2 Detect™ IgG ELISA kit (InBios International, Seattle, USA), an indirect ELISA that detects the presence of IgG antibodies against SARS-CoV-2 S proteins on human serum. The incurred sample reanalysis values above 1.1 were considered positive. The specificity of the SCoV-2 Detect™ IgG ELISA kit is reported to be 97.6% (Deshpande et al., 2021) . Similarly, Recombivirus TM Human Anti-Human Coronavirus NL63/OC43 Spike 1 IgG ELISA Kit (Alpha International diagnostics, USA) was used on human serum or plasma for quantifying IgG antibody specific for S1 subunit of the spike protein of the HCoV [NL63 (alpha coronavirus) and OC43 (betacoronavirus)] viruses, which are etiologic agents for human endemic respiratory disease. The incurred sample optical density values above 3.5 were considered positive.

The primary outcome assessed was seropositivity (seroprevalence)to SARS-CoV-2 antibodies overall and in different subgroups. The secondary outcomes included the various factors associated with seropositivity, symptomatic and asymptomatic infection, seropositivity to HCoV,and vaccination status.

The study was approved by the Institutional Review Board and Ethics Committee of CMC Vellore (Number: 13165).

A target sample size of 1000 participants was estimated for each time point to detect the differences by subpopulations (approximately 2,000 participants for both waves), assuming a seroprevalence in the general population of 20% at the end of wave 1, with an α error of 0·05 and power of 80%to detect at least a 12% difference in seroprevalence which gives a sample size of 225 per subpopulation. In order to account for a 10% loss to follow-up, from different subpopulations, 250 samples were targeted at each sampling period. The actual sample size that was sampled was 2,433 for both waves (1,228 for wave 1 and 1,205 for wave 2),which was slightly higher than the target sample size and, hencecontributed to a gain in power.

The summary measures of participants, seroprevalence, and odds ratios (ORs) with 95% confidence intervals (95% CI) were calculated by subpopulation, time period, and participant characteristics. The seroprevalence estimates were calculatedby subpopulation and previously known test performances.The overall seropositivity for each wave was weighted using the Vellore population. Post-stratification weighting was used to align the composition of the respondents' sampling fraction with the known distribution of the whole population's subgroup proportions, thereby reducing sampling error. Weights were computed based on the expected proportion of the population ofeach location.

Therisk factors for seropositivity were assessed by univariatemixed-effects logistic regression analysisclustered by time period.A p-value less than 0.05 were considered statistically significant. Multivariablemixed-effects logistic regression analysis was done to adjust for potential confounding factors and clustering effects. Statistically significant risk factors identified in univariate analysis were selected as variables for the multivariable analysis.

Statistical analyses were performed in SPSS version 21 and Stata 16College Station, Texas 77845 USA.

A total of 2,433 willing participants from four subpopulations namely Rural, Urban slums, Urban affluent, and Healthcare workers were included in this study. Sampleswere collected from these four subpopulations at the end of wave 1 in January 2021 and wave 2 in July 2021 to give a total of756 samples fromrural, 645 from the urban slum, 534 from urban affluent, and 498 from healthcare workers. The sample population constituted 56.6% females with a mean age of 37 years (SD± 17.5). Of the participants,18.7% were less than 20 years, 41.8% were between 21-40 years, 28.7% were between 41-60 years, and 10.9% were above 60 years. The most commonly reported comorbidities were diabetes (11.1%),hypertension (10.7%), chronic obstructive pulmonary disease (COPD)/asthma (2.1%), and heart diseases (1.4%). The subpopulation specific baseline demographic characteristics including education, occupation, and socioeconomic class aresummarised in Table 1. A total of 588 participants (24.2%) reported symptoms suggestive of acute respiratory infection or fever during the six months preceding sample collection. Symptoms were reported by 46.2% of healthcare workers,28.3% of the urban affluent group, 16.1% of the urban slum, and 13.4% of the rural group. Overall symptoms reported among participants were similar during wave 1(27.6%)and wave 2(20.7%). Among the SARS-CoV-2 positive participants,30.7%and 22.5% were symptomaticduring wave 1 and wave 2, respectively. Notably, only 4.1% of the study population had symptomatic infection requiring hospitalisation,most of which were for infection control purposes. In public places, cloth maskremained the most common type of mask used (58.1%)followed by surgical mask (35.1%), and N95(6.8%), respectively. Other human coronavirus antibodies (NL63, OC43) were detected in almost all the participants:99.6% of participants who were seronegative for SARS-CoV-2 and 100% of the participants who were seropositive for SARS-CoV-2 antibodies, respectively.

The overall weighted prevalence of SARS-CoV-2 antibodies adjusted for the population of Vellore was 28.5% (95% CI: 22.3%-33.7%) at the end of wave 1 and 71.6% (95% CI: 62.8%-80.5%) at the end of wave 2. At the end of wave 1, seroprevalence was found to be the maximum among individuals from urban slums ( 67.8%(95% CI: 63.1%-71.9%), respectively, with only 6.6%(95% CI: 4.2%-9.8%) and 10.4%(95% CI: 7.7%-13.5%) of respective participants being vaccinated.The community seropositivity for IgG at the end of wave 1 and wave 2 for the four different subpopulations is tabulated in Table 2 Table 3 .There was a slight shift in seropositivity noted from older age groups (above 60 and 40-60) in wave 1 to younger age groups years and 1-20 years) in wave 2. This may be because of the larger proportion of the population who got infected during the second wave which is a reflection of the younger population in the country.

Mixed-effects logistic regression analysis of factors associated with seropositivity was adjusted for the clustering of time periods (Table 4 ). Healthcare workers and individuals among the urban affluent showed 2.1 and 1.5 times higher odds for seropositivity as compared to the rural populationin the univariate analysis. However, these were not found to be significant in the and in multivariable analysis with an OR of 1.77 (95% CI: 1.17-2.67; p=0.007). Although skilled workers showed a 30% lower risk of seropositivity in univariate analysisas compared to professional workers, it was not found to be significant on multivariable analysis. Among the comorbidities, diabetes and hypertension showed 1.5-and 1.3-times higher odds for seropositivity in univariate analysis, respectively, as well asin multivariable analysis with an OR of 1.70(95% CI: 1.15-2.58; p=0.009) and 1.75(95% CI: 1.16-2.64; p=0.008), respectively. There was no significant difference in protection noted between the use of N95 mask and the use of cloth masks in public places. However, usage of surgical masksshowed slightly higher odds for seropositivity of 1.38(95% CI:1.13 -1.28; p-value=0.001) compared to cloth mask in univariate analysis.This was not found to be significant on multivariable analysis. Smoking habits and alcohol consumption were not found to be potential risk factors for seropositivity. The presence of symptoms suggestive of recent respiratory infection in the past 6 months and close contact with confirmed cases were not found to be an independent risk factor for COVID-19 infection.

Close contact with confirmed SARS-CoV-2 positive cases was also insignificant.

Our results reporteda high community seroprevalence of SARS-CoV-2in Vellore, India and it demonstrated the variability in transmission dynamics and vaccine utilisation in different subpopulations. The overall weighted seroprevalence for Vellore district increased almost threefolds from 28.5% at the end of wave 1 in January 2021 to 71.6% at the end of wave 2in July 2021 suggesting thatpopulation immunity was achieved. The transmission dynamics varied in different subpopulations. The seroprevalence was highest among the urban slum population both at the end of wave 1 (43.7%)and wave 2(75.1%). As the transmission progressed, the lower seroprevalences at the end of wave 1 among the rural and urban affluent increased rapidly at the end of wave 2 to 67.6% and 85.4%, respectively, and probably reachedconsiderable population immunity. The high seroprevalence achieved among the healthcare workers and the urban affluent perhaps is largely due to the high vaccination rate of 91.6% and 65.7%, respectively.Whereas it is likely the natural infection that caused the high seroprevalence among the rural and urban slum populationsince vaccination rates were low (10.4% and 6.6%, respectively) in these populations.The majority of individuals (75%) with positive SARS-CoV-2 antibody did not report any symptoms in the six months prior to sample collection, suggesting significant asymptomatic transmission in the community. Diabetes is an important risk factor for viral, bacterial, and fungal infections, presumably these emerging data may suggest that there is an increased risk for SARS CoV-2 infection. 13 The disease transmission among different age groups varied based on their exposure to infection at different time points during the pandemic. We found that there has been a shift in the seroprevalence among theage groups between wave 1 and wave 2which is similar to other observations (Laxminarayan et al.,2021 ,Miragliaet al.,2021 . Among urban slum, rural, and urban affluent subpopulations maximum seropositivity was seen in the 40-60years and above 60 years age groups after wave 1 but at the end of wave 2 slightly higher seropositivity rates were seen in the 1-20years and 20-40years age groups. An age-stratified regional modelling study from France predicted that wave 2 will affect the middle age groups and the younger population more, which is similar to our observations (Roederer et al.,2021) . To answer this question, we evaluated IgG antibodies against two endemic strainsof HCoV (NL63 and OC43) to analyse possible cross-protection against the current SARS-CoV-2 infection. We found almost 100% of participants were positive for HCoV antibodies. A similar estimate of high antibody titres due to acquisition of infection in early childhood is common. The major limitation of our study was that this data may not be representative of the rest of the country. However, observations from the nationwide serosurvey had a similar seroprevalence and hence this study adds value and provides deeper insight. The simple random sampling used in our study for convenience may have caused minimal estimation error. This method is what was practical and feasible as the apprehension among the general public to the COVID 19 pandemic posed a major hindrance to the willingness to participate in the study. has unusually large genomic RNA, error-prone proofreading mechanisms, and continues to mutate during infections. Therefore, well-coordinated genomic surveillance for emerging SARS CoV-2 variants is important.

In conclusion, our results confirm the high seroprevalence of SARS-CoV-2in Vellore and provide insights into the heterogeneity and various factors associated with transmission of infection. We also found that urban slum and rural subpopulations needed to be targeted for preventive strategies as they had the least vaccination status. Going forward, improved vaccination strategies among unreached subpopulations, particularly focussed vaccination in high-risk individuals are suggested for better preparedness in future. Additionally, a rational approach of single dose of vaccine for the majority who are already infected with positive antibodies and natural immunity could be considered. The meaningful inferences drawn can be utilised to target high-risk groups that warrant attention and to be better prepared to address challenges in future. 

The study was approved by the Institutional Review Board of Christian Medical College, Vellore (IRB minute 13165 dated 22.7.2020)

The authors have no conflicts of interest to declare. 

Large-Scale Screening of Asymptomatic Persons for SARS-CoV-2 Variants of Concern and Gamma Takeover, Brazil. Emerg Infect Dis

Three new estimates of deaths in India during the pandemic. Center for Global Development

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43

Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays

Epub ahead of print

Corona-Ômica Br/McTi Network. High Rate of Mutational Events in SARS-CoV

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

JHU CSSE Coronavirus COVID-19 Global Cases

Measuring Poverty in Southern India: A Comparison of Socio-Economic Scales Evaluated against Childhood Stunting

Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team. Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha

SARS-CoV-2 infection and mortality during the first epidemic wave in

Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection

An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai

A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo, Brazil. PLoS One

CHAMACOS-Project-19 Study Team. Risk Factors Associated With SARS-CoV-2 Infection Among Farmworkers in Monterey 21

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India

Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review

Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge

Mega festivals like MahaKumbh, a largest mass congregation, facilitated the transmission of SARS-CoV-2 to humans and endangered animals via contaminated water

Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India

Burden and characteristics of COVID-19 in the United States during 2020

Seroprevalence and risk factors of exposure to COVID-19 in homeless people

Low-income countries are more immune to COVID-19: A misconception

Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra. The Lancet Regional Health -Europe

Covid-19 Infection in India: A Comparative Analysis of the Second Wave with the First Wave. Pathogens

Metaanalysis and adjusted estimation of COVID-19 case fatality risk in India and its association with the underlying comorbidities. One Health

Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection

Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years

COVID-19 in India: Moving from containment to mitigation

Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

The SARS-CoV-2 outbreak: What we know

Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis

We gratefully acknowledge Rohini Karthikeyan, S. Suresh Kumar, Merylin Sebastian, Emily Devasagayam, Vivegh V, Priyanka Gautam and Mithun Mohan Georgefor their technical helpand support.